temp_copy

By Chandler Batchelor Chandler Batchelor is a graduate student in the Literature, Medicine, and Culture MA program at the University of North Carolina at Chapel Hill.  She is interested in alternative and holistic approaches to mental healthcare, doctor-patient relationships in mental healthcare, and mental health advocacy. Typically, descriptions of mental illness provided by medical professionals are often taken more seriously than descriptions given by the diagnosed themselves. Biomedicine has a particular way of talking about mental abnormalities, describing mental experiences with symptoms. It uses words like “depression,” “flat affect,” and “grandiose sense of self” to depict concrete outward signs of internal dysfunction. In our culture, this biomedical rhetoric is upheld as the definitive, most correct and objective way of describing mental illness. But while biomedicine is an excellent tool for describing diseases, it often fails to capture the subjective nuances of the i

By Ryan Purcell Image courtesy of Flickr user Day Donaldson “Never before in history has there been a situation when a bite from a mosquito can result in such a devastating scenario.” So says Tom Frieden , director of the US Centers for Disease Control and Prevention ( CDC ). The Zika virus has captured headlines since late 2015 , when word spread north from Brazil that a virus, new to the Americas, may be silently causing alarming neurodevelopmental disorders in newborns. Now, the southern United States is preparing to confront the mosquito-borne illness, which “may become the first great plague of the 21st century.” As public health officials continue to work to mitigate the impact of what the World Health Organization has  declared  a “Global Health Emergency”, there are several important ethical issues that must be considered. These include a women’s reproductive rights, disability rights concerning those most affected, and the growing realization that poverty-stricken regions an

By Anna Wexler Anna Wexler is a PhD candidate in the HASTS (History, Anthropology, Science, Technology and Society) at MIT and a 2015-2016 visiting scholar at the Center for Neuroscience and Society at the University of Pennsylvania. Her dissertation focuses on the ethical, legal and social implications of emerging neuroscience technology, with a particular focus on the home use of noninvasive brain stimulation. Just when it seemed like the consumer neurotechnology market couldn’t get any stranger—after all, who would’ve expected that a sleek white triangle could be placed on the forehead for “calm” or “energy” vibes—two new products recently hit the market that further complicate the challenges of regulating this emerging market. Halo Sport is a brain stimulator marketed for athletic enhancement that utilizes technology similar to transcranial direct current stimulation (tDCS), while Nervana , which began taking pre-orders in March, is the first noninvasive vagus nerve stimulation

Mark your calendars now for the 2016 International Neuroethics Society Annual Meeting taking place in San Diego, CA on November 11th and November 12th. This year the conference will feature 2 days of talks, networking opportunities, and poster presentations. Highlights from the meeting include Plenary Talks by Dr. Steve Hyman of the Stanley Center for Psychiatric Research and Dr. Walter J. Koroshetz from the National Institute of Neurological Disorders and Stroke (NINDS), while the two featured sessions on the 12th are entitled “Mind-Brain and the Competing Identities of Neuroethics” and “Deconstructing Therapeutic Neurotechnology 'Narratives': A Case Study of DBS for Depression.” Moderated by Dr. Eric Racine from the Institut de recherches cliniques de Montréal, “Mind-Brain and the Competing Identities of Neuroethics” will discuss three perspectives of neuroscience: empirical, speculative, and pragmatic, and these three views will be presented by Dr. Paul Applebaum , Dr. T